Neuberger Berman Group’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$109M Sell
1,729,163
-611,036
-26% -$42.6M 0.08% 293
2025
Q4
$155M Buy
2,340,199
+1,234,469
+112% +$79.8M 0.12% 207
2025
Q3
$74.4M Buy
1,105,730
+324,849
+42% +$25.7M 0.05% 394
2025
Q2
$68.2M Buy
780,881
+368,103
+89% +$28.9M 0.05% 396
2025
Q1
$28.2M Sell
412,778
-681,643
-62% -$55.6M 0.02% 548
2024
Q4
$85.1M Sell
1,094,421
-194,321
-15% -$14.4M 0.07% 329
2024
Q3
$86.4M Buy
1,288,742
+180,255
+16% +$14.8M 0.07% 318
2024
Q2
$126M Sell
1,108,487
-21,145
-2% -$2.67M 0.1% 238
2024
Q1
$157M Sell
1,129,632
-638,218
-36% -$80.2M 0.13% 204
2023
Q4
$219M Sell
1,767,850
-1,018,788
-37% -$104M 0.19% 140
2023
Q3
$262M Buy
2,786,638
+928,903
+50% +$105M 0.24% 104
2023
Q2
$238M Buy
1,857,735
+56,874
+3% +$6.88M 0.21% 128
2023
Q1
$207M Buy
1,800,861
+447,693
+33% +$50.1M 0.19% 143
2022
Q4
$152M Sell
1,353,168
-542,099
-29% -$59.5M 0.15% 189
2022
Q3
$155M Buy
1,895,267
+195,731
+12% +$16.6M 0.16% 178
2022
Q2
$128M Buy
1,699,536
+352,628
+26% +$32.2M 0.13% 224
2022
Q1
$172M Buy
1,346,908
+33,336
+3% +$3.65M 0.15% 198
2021
Q4
$175M Buy
1,313,572
+313,600
+31% +$45.1M 0.14% 216
2021
Q3
$135M Sell
999,972
-425,364
-30% -$53.6M 0.12% 255
2021
Q2
$151M Sell
1,425,336
-803,756
-36% -$77.2M 0.13% 239
2021
Q1
$200M Sell
2,229,092
-215,048
-9% -$20.2M 0.19% 158
2020
Q4
$226M Buy
2,444,140
+1,215,960
+99% +$109M 0.23% 120
2020
Q3
$126M Sell
1,228,180
-50,364
-4% -$5.26M 0.15% 192
2020
Q2
$129M Sell
1,278,544
-544,780
-30% -$48.7M 0.16% 173
2020
Q1
$123M Buy
1,823,324
+1,362,964
+296% +$84.8M 0.19% 149
2019
Q4
$25.2M Sell
460,360
-14,984
-3% -$711K 0.03% 544
2019
Q3
$17.7M Buy
475,344
+18,492
+4% +$718K 0.02% 602
2019
Q2
$17.1M Sell
456,852
-696
-0.2% -$21.9K 0.02% 638
2019
Q1
$13.6M Sell
457,548
-78,240
-15% -$2.75M 0.02% 677
2018
Q4
$16M Sell
535,788
-50,576
-9% -$1.6M 0.02% 621
2018
Q3
$21M Buy
586,364
+196
+0% +$6.08K 0.02% 634
2018
Q2
$13.9M Sell
586,168
-1,963,496
-77% -$41.6M 0.02% 739
2018
Q1
$47.3M Buy
2,549,664
+2,126,052
+502% +$31.4M 0.05% 417
2017
Q4
$6.08M Sell
423,612
-1,118,072
-73% -$14.5M 0.01% 853
2017
Q3
$18.9M Buy
1,541,684
+544,820
+55% +$9.63M 0.02% 623
2017
Q2
$18.2M Buy
996,864
+430,660
+76% +$7.95M 0.02% 628
2017
Q1
$12M Buy
+566,204
New +$11.1M 0.02% 716
2016
Q4
Sell
-666,476
Closed -$14.6M 1603
2016
Q3
$14.6M Sell
666,476
-323,872
-33% -$7.21M 0.02% 676
2016
Q2
$19.6M Sell
990,348
-163,452
-14% -$2.78M 0.03% 592
2016
Q1
$19.6M Buy
1,153,800
+234,000
+25% +$3.91M 0.03% 594
2015
Q4
$18.8M Sell
919,800
-18,844
-2% -$392K 0.02% 624
2015
Q3
$20.1M Buy
938,644
+856,400
+1,041% +$19.1M 0.03% 630
2015
Q2
$1.64M Sell
82,244
-8,400
-9% -$148K ﹤0.01% 1106
2015
Q1
$1.41M Buy
90,644
+21,200
+31% +$320K ﹤0.01% 1140
2014
Q4
$955K Buy
+69,444
New +$850K ﹤0.01% 1228
2014
Q1
Sell
-34,160
Closed -$302K 1624
2013
Q4
$302K Hold
34,160
﹤0.01% 1430
2013
Q3
$241K Sell
34,160
-399,284
-92% -$2.53M ﹤0.01% 1471
2013
Q2
$2.43M Buy
+433,444
New +$2.08M ﹤0.01% 998

Other funds holding DXCM

Neuberger Berman Group's DXCM Position: Q1 2026 in Review

Neuberger Berman Group reduced its DexCom (DXCM) stake by 26% in Q1 2026, selling an estimated $42.6M and leaving 1,729,163 shares worth $109M. The position accounts for 0.08% of the portfolio, ranked #293.

Neuberger Berman Group first reported a position in DXCM in Q2 2013 and has held it in 48 quarters since. The position peaked at $262M in Q3 2023. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Neuberger Berman Group held 1,729,163 shares of DexCom worth $109M as of Q1 2026.
  • Neuberger Berman Group sold 611,036 DexCom shares in Q1 2026, an estimated $42.6M.
  • DexCom made up 0.08% of Neuberger Berman Group's portfolio in Q1 2026, its #293 holding.
  • Neuberger Berman Group first reported a position in DexCom in Q2 2013 and has held it in 48 quarters since.
  • Neuberger Berman Group's DexCom position peaked at $262M in Q3 2023.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.